IL-2 dose regulates TNF-alpha mRNA transcription and protein secretion in human peripheral blood lymphocytes

Cell Immunol. 1991 Jan;132(1):193-200. doi: 10.1016/0008-8749(91)90018-7.

Abstract

TNF-alpha is an inducible cytokine with widely divergent effects on numerous target tissues. Secretion and response to TNF-alpha appear to be required in cellular immune function including that of classical cytotoxic T cell development, non-MHC restricted cytotoxicity, and the mixed lymphocyte reaction. In addition, production of TNF-alpha has been implicated in a number of pathophysiologic processes involving lymphocytes. In this report, we have investigated the regulation of TNF-alpha in normal lymphocytes stimulated with IL-2. Our results demonstrate that the level of TNF-alpha gene expression can be determined by the quantity of IL-2 present during lymphocyte activation. The increased steady-state levels of TNF-alpha mRNA were attributable to an enhanced rate of nuclear transcription. TNF-alpha secretion increased with escalating IL-2 dose in parallel to that of mRNA production. The modulation of TNF-alpha gene expression by IL-2 concentration has been previously unrecognized and may be an important mechanism in normal immunohomeostasis, cellular dysregulations involving TNF production, and the dose-dependent toxicities observed with high-dose IL-2 immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blotting, Northern
  • Cell Nucleus / physiology
  • Dose-Response Relationship, Drug
  • Gene Expression / drug effects
  • Humans
  • In Vitro Techniques
  • Interleukin-2 / pharmacology*
  • Lymphocytes / physiology*
  • RNA, Messenger / genetics
  • Secretory Rate / drug effects
  • Transcription, Genetic / drug effects
  • Tumor Necrosis Factor-alpha / genetics*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-2
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha